169 related articles for article (PubMed ID: 28751806)
1. A marine bio-functional lipid, fucoxanthinol, attenuates human colorectal cancer stem-like cell tumorigenicity and sphere formation.
Terasaki M; Maeda H; Miyashita K; Tanaka T; Miyamoto S; Mutoh M
J Clin Biochem Nutr; 2017 Jul; 61(1):25-32. PubMed ID: 28751806
[TBL] [Abstract][Full Text] [Related]
2. Induction of Anoikis in Human Colorectal Cancer Cells by Fucoxanthinol.
Terasaki M; Maeda H; Miyashita K; Mutoh M
Nutr Cancer; 2017 Oct; 69(7):1043-1052. PubMed ID: 28990814
[TBL] [Abstract][Full Text] [Related]
3. Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
Terasaki M; Mima M; Kudoh S; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Oncol Rep; 2018 Jul; 40(1):414-424. PubMed ID: 29693702
[TBL] [Abstract][Full Text] [Related]
4. Does squalene alter the antioxidant potential of astaxanthin and fucoxanthinol? In vitro evidence in RAW 264.7 cells, a murine macrophage.
Ravi Kumar S; Narayan B; Kizawa Y; Hosokawa M; Miyashita K
J Food Sci Technol; 2016 Apr; 53(4):2139-43. PubMed ID: 27413244
[TBL] [Abstract][Full Text] [Related]
5. Fucoxanthin administration delays occurrence of tumors in xenograft mice by colonospheres, with an anti-tumor predictor of glycine.
Terasaki M; Matsumoto N; Hashimoto R; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
J Clin Biochem Nutr; 2019 Jan; 64(1):52-58. PubMed ID: 30705512
[TBL] [Abstract][Full Text] [Related]
6. Glycine Is a Predictor for a Suppressive Effect of Fucoxanthinol on Colonosphere Formation Under Hypoxia.
Terasaki M; Ogawa Y; Endo T; Maeda H; Hamada J; Osada K; Miyashita K; Mutoh M
Anticancer Res; 2018 Apr; 38(4):2169-2179. PubMed ID: 29599336
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of fucoxanthin and fucoxanthinol on colorectal cancer cell lines and colorectal cancer tissues.
Takahashi K; Hosokawa M; Kasajima H; Hatanaka K; Kudo K; Shimoyama N; Miyashita K
Oncol Lett; 2015 Sep; 10(3):1463-1467. PubMed ID: 26622691
[TBL] [Abstract][Full Text] [Related]
8. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K
Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166
[TBL] [Abstract][Full Text] [Related]
9. Fucoxanthin Inhibits Development of Sigmoid Colorectal Cancer in a PDX Model With Alterations of Growth, Adhesion, and Cell Cycle Signals.
Terasaki M; Tsuruoka K; Tanaka T; Maeda H; Shibata M; Miyashita K; Kanemitsu Y; Sekine S; Takahashi M; Yagishita S; Hamada A
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):686-705. PubMed ID: 38035706
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.
Asai A; Sugawara T; Ono H; Nagao A
Drug Metab Dispos; 2004 Feb; 32(2):205-11. PubMed ID: 14744942
[TBL] [Abstract][Full Text] [Related]
11. Salivary Glycine Is a Significant Predictor for the Attenuation of Polyp and Tumor Microenvironment Formation by Fucoxanthin in AOM/DSS Mice.
Terasaki M; Masaka S; Fukada C; Houzaki M; Endo T; Tanaka T; Maeda H; Miyashita K; Mutoh M
In Vivo; 2019; 33(2):365-374. PubMed ID: 30804114
[TBL] [Abstract][Full Text] [Related]
12. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
[TBL] [Abstract][Full Text] [Related]
13. Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment.
Martin LJ
Mar Drugs; 2015 Jul; 13(8):4784-98. PubMed ID: 26264004
[TBL] [Abstract][Full Text] [Related]
14. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells.
Terasaki M; Takahashi S; Nishimura R; Kubota A; Kojima H; Ohta T; Hamada J; Kuramitsu Y; Maeda H; Miyashita K; Takahashi M; Mutoh M
Nutr Cancer; 2022; 74(1):357-371. PubMed ID: 33590779
[TBL] [Abstract][Full Text] [Related]
15. Fucoxanthinol, Metabolite of Fucoxanthin, Improves Obesity-Induced Inflammation in Adipocyte Cells.
Maeda H; Kanno S; Kodate M; Hosokawa M; Miyashita K
Mar Drugs; 2015 Aug; 13(8):4799-813. PubMed ID: 26248075
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of fucoxanthin and fucoxanthinol against tributyltin-induced oxidative stress in HepG2 cells.
Zeng J; Zhang Y; Ruan J; Yang Z; Wang C; Hong Z; Zuo Z
Environ Sci Pollut Res Int; 2018 Feb; 25(6):5582-5589. PubMed ID: 29222657
[TBL] [Abstract][Full Text] [Related]
17. Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice.
Sugawara T; Baskaran V; Tsuzuki W; Nagao A
J Nutr; 2002 May; 132(5):946-51. PubMed ID: 11983819
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-glycolipid nanogels loaded with anti-obese marine carotenoid fucoxanthin: Acute and sub-acute toxicity evaluation in rodent model.
Ravi H; Arunkumar R; Baskaran V
J Biomater Appl; 2015 Oct; 30(4):420-34. PubMed ID: 26084499
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects between fucoxanthinol and its precursor fucoxanthin on viability and apoptosis of breast cancer cell lines MCF-7 and MDA-MB-231.
Rwigemera A; Mamelona J; Martin LJ
Anticancer Res; 2015 Jan; 35(1):207-19. PubMed ID: 25550553
[TBL] [Abstract][Full Text] [Related]
20. Fucoxanthin potentiates anoikis in colon mucosa and prevents carcinogenesis in AOM/DSS model mice.
Terasaki M; Iida T; Kikuchi F; Tamura K; Endo T; Kuramitsu Y; Tanaka T; Maeda H; Miyashita K; Mutoh M
J Nutr Biochem; 2019 Feb; 64():198-205. PubMed ID: 30530259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
